Boundless Bio, Inc.
For the period ended Dec 31, 2025. Filed Mar 9, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 9, 2026
BOLD$2.45-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(1)
For a list of the financial statements included herein, see Index to the Financial Statements on page F-1 of this Annual Report on Form 10-K, incorporated into this Item by reference.
(2)
Financial statement schedules have been omitted because they are either not required or not applicable or the information is included in the financial statements or the notes thereto.
(3)
Exhibits:
Exhibit Index
| Exhibit · Incorporated by Reference · Filed | |||||
|---|---|---|---|---|---|
| Number | Description | Form | Date | Number | Herewith |
| 3.1 | Amended and Restated Certificate of Incorporation | 8-K | 4/2/2024 | 3.1 | |
| 3.2 | Amended and Restated Bylaws | 8-K | 4/2/2024 | 3.2 | |
| 4.1 | Specimen stock certificate evidencing the shares of common stock | S-1/A | 3/21/2024 | 4.1 | |
| 4.2 | Amended and Restated Investor Rights Agreement, dated April 5, 2023, by and among the Registrant and certain of its stockholders | S-1 | 3/6/2024 | 4.2 | |
| 4.3 | Description of the Registrant’s securities | 10-K | 3/27/2025 | 4.3 | |
| 10.1# | Boundless Bio, Inc. 2018 Equity Incentive Plan, as amended, and form of stock option agreement and form of restricted stock agreement thereunder | S-1 | 3/6/2024 | 10.1 | |
| 10.2# | Boundless Bio, Inc. 2024 Incentive Award Plan and form of stock option agreement and form of restricted stock unit agreement thereunder | S-1/A | 3/21/2024 | 10.2 | |
| 10.3# | Boundless Bio, Inc. 2024 Employee Stock Purchase Plan | S-1/A | 3/21/2024 | 10.3 | |
| 10.4# | Non-Employee Director Compensation Program (as amended and restated effective March 27, 2025) | 10-Q | 5/9/2025 | 10.1 | |
| 10.5# | Amended and Restated Employment Offer Letter Agreement, dated March 5, 2024, between Zachary D. Hornby and the Registrant | S-1 | 3/6/2024 | 10.6 | |
| 10.6# | Amended and Restated Employment Offer Letter Agreement, dated March 5, 2024, between Christian Hassig, Ph.D. and the Registrant | S-1 | 3/6/2024 | 10.12 | |
| 10.7# | Amended and Restated Employment Offer Letter Agreement, dated March 5, 2024, between Jessica Oien and the Registrant | S-1 | 3/6/2024 | 10.16 | |
| 10.8# | Amended and Restated Employment Offer Letter Agreement, dated April 2, 2024, between David Hinkle and the Registrant | 10-K | 3/27/2025 | 10.8 | |
| 10.9# | Employment Offer Letter Agreement, dated January 27, 2025, between Robert Doebele, M.D. Ph.D. and the Registrant | 10-K | 3/27/2025 | 10.9 | |
| 10.11# | Severance and Change in Control Severance Plan | S-1 | 3/6/2024 | 10.17 | |
| 10.12# | Corporate Bonus Plan | S-1 | 3/6/2024 | 10.18 | |
| 10.13# | Form of Indemnification Agreement for Directors and Officers | S-1/A | 3/21/2024 | 10.19 | |
| 10.14 | Lease Agreement, dated December 20, 2021, between ARE-10933 NORTH TORREY PINES, LLC, and the Registrant | 10-Q | 5/9/2025 | 10.3(a) | |
| 10.15 | First Amendment to the Lease Agreement, dated November 1, 2024, between ARE-10933 NORTH TORREY PINES, LLC, and the Registrant | 10-Q | 5/9/2025 | 10.3(b) | |
| 19.1 | Boundless Bio, Inc. Insider Trading Compliance Policy and Procedures | 10-K | 3/27/2025 | 19.1 | |
| 23.1 | Consent of KPMG LLP, independent registered public accounting firm | X | |||
| 24.1 · Power of attorney (included on signature page) · X | |||||
|---|---|---|---|---|---|
| 31.1 · Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. · X | |||||
| 31.2 · Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. · X | |||||
| 32.1* · Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. · X | |||||
| 97.1# | Policy for Recovery of Erroneously Awarded Compensation | S-1 | 3/6/2024 | 10.20 | |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | X | |||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | X | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.